echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > The Lancet: How much uric acid needs to be reduced to reduce gout attacks

    The Lancet: How much uric acid needs to be reduced to reduce gout attacks

    • Last Update: 2022-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hyperuricemia and gout are inseparable


     

    Regarding this issue, the "American Association of Physicians Clinical Practice Guidelines : Management of Acute and Recurrent Gout " published in 2017 believes that most patients with gout for the first time, or patients with infrequent gout attacks, do not recommend long-term uric acid-lowering therapy


     

    Since there is no need to pursue the blind reduction of uric acid levels, is there a definite "uric acid red line" to guide the uric acid control drug regimen to reduce gout attacks?

     

    1

    How much uric acid to control

    Can reduce gout attacks?

     

    Recently, a study published in The Lancet Rheumatology (The Lancet Rheumatology) gives the answer


     

    Image source: Screenshot of the official website of The Lancet Rheumatology

     

    1.


     

    The researchers analyzed individual patient-level data from two randomized trials of uric acid lowering in Nottingham, UK and New Zealand:

     

    New Zealand trial: a total of 71 participants, with an average age of 60.


    Nottingham Trial: 517 participants, mean age 62.


     

    All patients in the New Zealand trial and 441 patients in the Nottingham trial completed all 24 months of follow-up


     

    2.


     

    Main results: Serum uric acid responders had significantly fewer gout flares than serum uric acid non-responders between 12 and 24 months—91 of 343 (27%) vs 156 of 245 (64%); p <0.


     

    Secondary Outcomes: Between 12 and 24 months, the mean number of episodes per month in serum uric acid responders was significantly lower than in serum uric acid non-responders (p<0.


     

    Therefore, this study concluded that achieving a mean serum uric acid concentration below 6 mg/dl (<360 μmol/L) was associated with no gout flare and a reduction in the number of gout flares in the 12-month period thereafter


     

    2

    Recommendations for gout management in my country

     

    From the above, in the management of gout, targeting serum uric acid level below 360 μmol/L can significantly reduce the number of gout attacks


     

    The guidelines believe that hyperuricemia and gout are systemic diseases involving multiple systems.


     

    1.


     

    1) Control your weight and exercise regularly;

    2) Limit the intake of alcohol and foods high in purine and fructose;

    3) Encouraging the intake of dairy products and fresh vegetables and drinking water in moderation;

    4) The intake of soy products (such as tofu) is not recommended or restricted


     

    Hyperuricemia and gout are inseparable


     

    Regarding this issue, the "American Association of Physicians Clinical Practice Guidelines : Management of Acute and Recurrent Gout " published in 2017 believes that most patients with gout for the first time, or patients with infrequent gout attacks, do not recommend long-term uric acid-lowering therapy
    .

    Guidelines manage most patients with gout for the first time, or those with infrequent gout attacks, and do not recommend long-term urate-lowering therapy
    .

     

    Since there is no need to pursue the blind reduction of uric acid levels, is there a definite "uric acid red line" to guide the uric acid control drug regimen to reduce gout attacks?

     

    1

    1

    How much uric acid to control

    How much uric acid to control

    Can reduce gout attacks?

    Can reduce gout attacks?

     

    Recently, a study published in The Lancet Rheumatology (The Lancet Rheumatology) gives the answer
    .
    The article pointed out that when the serum uric acid concentration continued to average < 360 μmol/L, it could effectively reduce the risk of gout attacks in the following 1 year and reduce the number of attacks
    .
    With or without symptoms, it is very important for patients with gout to achieve uric acid control
    .

    When the Lancet serum uric acid concentration is sustained on average < 360 μmol/L, it can effectively reduce the risk of gout attacks in the following 1 year, and reduce the number of attacks
    .
    With or without symptoms, it is very important for patients with gout to achieve uric acid control
    .

     

    Image source: Screenshot of the official website of The Lancet Rheumatology

     

    1.
    Research population and methods:

    1.
    Research population and methods:

     

    The researchers analyzed individual patient-level data from two randomized trials of uric acid lowering in Nottingham, UK and New Zealand:

     

    New Zealand trial: a total of 71 participants, with an average age of 60.
    1 years;

    Nottingham Trial: 517 participants, mean age 62.
    9 years
    .

     

    All patients in the New Zealand trial and 441 patients in the Nottingham trial completed all 24 months of follow-up
    .
    Patients with a mean serum uric acid concentration <360 μmol/L after treatment were defined as serum uric acid responders based on data at 6, 9, and 12 months after baseline
    .

     

    2.
    Research results

    2.
    Research results

     

    Main results: Serum uric acid responders had significantly fewer gout flares than serum uric acid non-responders between 12 and 24 months—91 of 343 (27%) vs 156 of 245 (64%); p <0.
    0001
    .

     

    Secondary Outcomes: Between 12 and 24 months, the mean number of episodes per month in serum uric acid responders was significantly lower than in serum uric acid non-responders (p<0.
    0001)
    .
    This association was independent of the initial randomized treatment assignment
    .

     

    Therefore, this study concluded that achieving a mean serum uric acid concentration below 6 mg/dl (<360 μmol/L) was associated with no gout flare and a reduction in the number of gout flares in the 12-month period thereafter
    .

     

    2

    2

    Recommendations for gout management in my country

    Recommendations for gout management in my country

     

    From the above, in the management of gout, targeting serum uric acid level below 360 μmol/L can significantly reduce the number of gout attacks
    .
    What is exciting is that this treatment goal is consistent with the uric acid control goal for gout patients in the "China Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout (2019)" released by China in 2019!

    diagnosis and treatment

     

    The guidelines believe that hyperuricemia and gout are systemic diseases involving multiple systems.
    In addition to uric acid control, patients should also pay attention to many aspects.
    The recommendations are as follows:

     

    1.
    All hyperuricemia and gout patients need to maintain a healthy life>

    1.
    All hyperuricemia and gout patients need to maintain a healthy life> 1.
    All hyperuricemia and gout patients need to maintain a healthy life>

     

    1) Control your weight and exercise regularly;

    2) Limit the intake of alcohol and foods high in purine and fructose;

    3) Encouraging the intake of dairy products and fresh vegetables and drinking water in moderation;

    4) The intake of soy products (such as tofu) is not recommended or restricted
    .

     

     

     

    2.
    Continue to pay attention to the influencing factors of serum uric acid level

    2.
    Continue to pay attention to the influencing factors of serum uric acid level 2.
    Continue to pay attention to the influencing factors of serum uric acid level

     

    Always control serum uric acid levels within the target range: 240-420 μmol/L, and may take uric acid-lowering drugs for a long time or even life for this purpose
    .

     

    3.
    Understand the possible hazards of disease

    3.
    Understand the possible harms of the disease 3.
    Understand the possible harms of the disease

     

    Regular screening and monitoring of target organ damage and timely treatment of related complications, in order to early detection and early treatment, improve the overall prognosis of patients
    .

    screening

     

    4.
    Timing and control goals of initiating urate-lowering drug therapy in gout patients

    4.
    Timing and control goals of initiating uric acid-lowering drug therapy in gout patients 4.
    Timing and control goals of initiating uric acid-lowering drug therapy in gout patients

     

    • For gout patients, when serum uric acid is ≥480 μmol/L, it is recommended to start uric acid-lowering drug therapy;

    • Serum uric acid ≥ 420 μmol/L and any of the following conditions, start uric acid-lowering drug therapy: gout attacks ≥ 2 times/year, tophi, chronic gouty arthritis, kidney stones, chronic kidney disease, hypertension , Diabetes , dyslipidemia, stroke , ischemic heart disease, heart failure and age of onset <40 years;

    • It is recommended to start uric acid-lowering drug treatment 2 to 4 weeks after the acute attack of gout is completely relieved.
      For patients with acute gout attack who are taking uric acid-lowering drugs, it is not recommended to stop uric acid-lowering drugs;

    • It is recommended that patients with gout control serum uric acid <360 μmol/L, and when one of the above conditions is combined, control serum uric acid level <300 μmol/L;

    • Long-term control of serum uric acid below 180 μmol/L is not recommended
      .

  • For gout patients, when serum uric acid is ≥480 μmol/L, it is recommended to start uric acid-lowering drug therapy;

  • For gout patients, when serum uric acid is ≥480 μmol/L, it is recommended to start uric acid-lowering drug therapy;

  • Serum uric acid ≥ 420 μmol/L and any of the following conditions, start uric acid-lowering drug therapy: gout attacks ≥ 2 times/year, tophi, chronic gouty arthritis, kidney stones, chronic kidney disease, hypertension , Diabetes , dyslipidemia, stroke , ischemic heart disease, heart failure and age of onset <40 years;

  • Serum uric acid ≥ 420 μmol/L and any of the following conditions, start uric acid-lowering drug therapy: gout attacks ≥ 2 times/year, tophi, chronic gouty arthritis, kidney stones, chronic kidney disease, hypertension , Diabetes , dyslipidemia, stroke , ischemic heart disease, heart failure and age of onset <40 years;

    hypertension diabetes stroke
  • It is recommended to start uric acid-lowering drug treatment 2 to 4 weeks after the acute attack of gout is completely relieved.
    For patients with acute gout attack who are taking uric acid-lowering drugs, it is not recommended to stop uric acid-lowering drugs;

  • It is recommended to start uric acid-lowering drug treatment 2 to 4 weeks after the acute attack of gout is completely relieved.
    For patients with acute gout attack who are taking uric acid-lowering drugs, it is not recommended to stop uric acid-lowering drugs;

  • It is recommended that patients with gout control serum uric acid <360 μmol/L, and when one of the above conditions is combined, control serum uric acid level <300 μmol/L;

  • It is recommended that patients with gout control serum uric acid <360 μmol/L, and when one of the above conditions is combined, control serum uric acid level <300 μmol/L;

  • Long-term control of serum uric acid below 180 μmol/L is not recommended
    .

  • Long-term control of serum uric acid below 180 μmol/L is not recommended
    .

     

    references:

    [1] Lisa K Stamp, Christopher Frampton, JasvinderA Singh, et al.
    , (2021).
    Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of tworandomised controlled trials.
    The Lancet Rheumatology.
    DOI: https://doi.
    org/10.
    1016/S2665-9913(21)00319-2

    [2] Endocrinology Branch of Chinese Medical Association.
    Guidelines for the diagnosis and treatment of hyperuricemia and gout in China (2019).
    Chinese Journal of Endocrinology and Metabolism [J].
    2020, 01(36): 1-13.

    ▲Swipe up and down to view▼

     

    Recommended in the past

    Recommended in the past Recommended in the past

    1.
    5%-10% of B27-negative patients are diagnosed with ankylosing spondylitis

    1.
    5%-10% of B27-negative patients are diagnosed with ankylosing spondylitis 5%-10% of B27-negative patients are diagnosed with ankylosing spondylitis

    2.
    Answers to common medication questions for ankylosing spondylitis

    2.
    Answers to common medication problems for ankylosing spondylitis

    3.
    Is the gout attack ineffective in the process of lowering uric acid? The most complete diagnosis and treatment plan is here, hurry up and collect it!

    3.
    Is the gout attack ineffective in the process of lowering uric acid? The most complete diagnosis and treatment plan is here, hurry up and collect it! Is the gout attack ineffective during the process of lowering uric acid? The most complete diagnosis and treatment plan is here, hurry up and collect it!

    4.
    [Case Interpretation ] What should I do if the tophi ruptures?

    4.
    [Case Interpretation ] What should I do if the tophi ruptures? [Case interpretation

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.